Cherry Tree Wealth Management, LLC Larimar Therapeutics, Inc. Transaction History
Cherry Tree Wealth Management, LLC
- $430 Billion
- Q2 2025
A detailed history of Cherry Tree Wealth Management, LLC transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Cherry Tree Wealth Management, LLC holds 10,618 shares of LRMR stock, worth $35,888. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,618Holding current value
$35,888% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding LRMR
# of Institutions
153Shares Held
89MCall Options Held
6.44MPut Options Held
622K-
Deerfield Management Company, L.P. (Series C) New York, NY30.6MShares$103 Million1.84% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$20.4 Million0.34% of portfolio
-
Blue Owl Capital Holdings LP New York, NY5.85MShares$19.8 Million8.2% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.9MShares$16.6 Million0.01% of portfolio
-
Opaleye Management Inc. Boston, MA3.72MShares$12.6 Million2.0% of portfolio
About Larimar Therapeutics, Inc.
- Ticker LRMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,269,200
- Market Cap $146M
- Description
- Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...